Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.49 |
| ▸ | GMNN | O75496 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2163300 | 1.00 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL93717 | 1.00 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27925466 | 0.93 | LMNA (0.66) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27768779 | 0.93 | LMNA (0.66) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27493791 | 0.92 | LMNA (0.64) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27469410 | 0.89 | LMNA (0.60) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| Zinc Ion SCHEMBL7620932 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27669980 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL2507637 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL3899729 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120078664-A | Hair-fixing and hair-losing-preventing composition and application thereof, and hair-fixing and hair-preventing be temporarily released from one's regular work product | 上海中翊日化有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120053314-A | Hair-fixing and hair-losing-preventing composition and application thereof, and hair-fixing and hair-preventing be temporarily released from one's regular work product | 上海中翊日化有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-118845516-A | Alopecia preventing composition and application thereof | 上海中翊日化有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20240324593-A1 | OCTENIDINE COMPOSITIONS AND METHODS OF USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-10-03 | — | — | US | claimed |
| CN-118388631-A | Anti-hair loss essence containing recombinant human XVII collagen and preparation method thereof | 西安巨子生物基因技术股份有限公司 | 2024-07-26 | — | — | CN | claimed |
| EP-4373276-A1 | OCTENIDINE COMPOSITIONS AND METHODS OF USE THEREOF | Solventum Intellectual Properties Company (US) | 2024-05-29 | — | — | EP | claimed |
| CN-117677295-A | Octenidine compositions and methods of use thereof | 3M创新有限公司 | 2024-03-08 | — | — | CN | claimed |
| WO-2023194470-A1 | IMPROVING SEMEN QUALITY | THE CEUTICS COMPANY GESMBH (AT) | 2023-10-12 | — | — | WO | claimed |
| EP-4243804-A1 | SUBSTANCES FOR TREATMENT OF HYPERURICAEMIA | ScandiBio Therapeutics AB (SE) | 2023-09-20 | — | — | EP | claimed |
| EP-3220893-B1 | COMPOSITION BASED ON COQ10 | ASOLTECH SRL (IT) | 2023-06-07 | — | — | EP | claimed |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | claimed |
| WO-2008107197-A2 | NUTRIENT COMPOSITIONS | PHARES PHARMACEUTICAL RESEARCH N.V. (AN) | 2008-09-12 | — | — | WO | claimed |
| EP-1964555-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTANCES THAT INHIBIT THE REUPTAKE OF NORADRENALINE, DOPAMINE AND SEROTONIN, WHICH ARE COMBINED WITH AN AMINO ACID FOR THE TREATMENT OF OBESITY AND OVERWEIGHT | Espinosa Abdala, Leopoldo de Jesús (MX) | 2008-09-03 | — | — | EP | claimed |
| WO-2005123108-A2 | ADVANCED VITAMINS AND PROTEIN BASED NUTRITIONAL SUPPLEMENTS | FEINSTEIN WILLIAM (US) | 2005-12-29 | — | — | WO | claimed |
| US-20040052926-A1 | Dietetic food for breaking down fat | APFELBAUM UDO (CH) | 2004-03-18 | — | — | US | claimed |
| US-6528042-B1 | Non-naturally-occurring compositions for use in amelioration of disruption of energy metabolism secondary to stress are described. These compositions comprise a flavonoid or derivative thereof and a synergist. Synergists include such as | GALILEO LABORATORIES, INC. | 2003-03-04 | — | — | US | claimed |
| CN-1248967-A | Process for the preparation of stable non-hygroscopic salts of L -carnitine and alkanoyl L -carnitines | SIGMA TAU IND FARMACEUTI (IT) | 2000-03-29 | — | — | CN | claimed |
| EP-0497834-A1 | CARNITINE SUPPLEMENTED CAT FISH DIET | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-08-12 | — | — | EP | claimed |
| US-5030657-A | Fat reduction, ammonia resistance | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1991-07-09 | — | — | US | claimed |
| WO-1991005554-A1 | CARNITINE SUPPLEMENTED CAT FISH DIET | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1991-05-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | LMNA 2570/4885SMN1; SMN2 2049/4885MEN1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.